December 15, 2025

PSVT Drug Approved for First Time in Decades

A self-administered intranasal calcium channel blocker enables treatment outside emergency department settings for acute paroxysmal supraventricular tachycardia episodes.

Conexiant

December 12, 2025

Nine Breakthrough Studies Define 2025 Research

From GLP-1 cardioprotection to genome sequencing in newborns, this year's top research spans critical clinical frontiers.

Conexiant

December 10, 2025

Report Looks at the Impact of High Altitude on Healthy Males 

After moving to high altitudes above 4,300 meters, 2 previously healthy young men with normal cardiopulmonary function developed high-altitude pulmonary hypertension

Conexiant

December 08, 2025

The Case of the Hospital That Isn’t

A bureaucratic showdown over North Carolina’s certificate-of-need laws has stalled a critical hospital project, straining care in the state’s mountain communities.

Conexiant

December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

November 25, 2025

ACP Calls for Managed Care Reform

Position paper targets prior authorization burdens, network inadequacy as enrollment surges across Medicare, Medicaid, and commercial insurance.

Conexiant

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 24, 2025

Holiday Habits Tied to AF Risks

Seasonal patterns hinted at arrhythmias after festive overindulgence.

Conexiant